Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

MANKIND PHARMA LTD.

NSE : MANKINDBSE : 543904ISIN CODE : INE634S01028Industry : Pharmaceuticals & DrugsHouse : Private

BSE2652.9512.35 (+0.47 %)

PREV CLOSE ( ) 2640.60

OPEN PRICE ( ) 2649.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8748

TODAY'S LOW / HIGH ( )2626.70 2667.60

52 WK LOW / HIGH ( )1910.1 3050

NSE2652.3013 (+0.49 %)

PREV CLOSE( ) 2639.30

OPEN PRICE ( ) 2640.00

BID PRICE (QTY) 2652.30 (30)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 421325

TODAY'S LOW / HIGH( ) 2627.00 2668.90

52 WK LOW / HIGH ( )1901.05 3054.8

Quarters

Select year

( in Million)

Particulars

Mar 2025

Dec 2024

Sep 2024

Jun 2024

Audited / UnAudited

UnAudited

Net Sales

30793.7

32300

30765.1

28934.2

Total Expenditure

23961.8

24002

22264.7

22116.6

PBIDT (Excl OI)

6831.9

8298

8500.4

6817.6

Other Income

2513.3

773.2

1094.3

1006

Operating Profit

9345.2

9071.2

9594.7

7823.6

Interest

1905.4

2209.3

109.1

Exceptional Items

PBDT

7439.8

6861.9

9523.7

7714.5

Depreciation

2308.7

1923

1056.2

1077.4

Profit Before Tax

5131.1

4938.9

8467.5

6637.1

Tax

864.4

1128.1

1904.4

1245.5

Provisions and contingencies

Profit After Tax

4266.7

3810.8

6563.1

5391.6

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

4223.3

3810.8

6563.1

5391.6

Minority Interest

-38.8

-42.9

-54.1

-65.8

Shares of Associates

23.2

34.4

25.7

39.1

Other related items

Misc. Expenses Written off

Consolidated Net Profit

4207.7

3802.3

6534.7

5364.9

Equity Capital

412.6

412.57

400.6

400.59

Face Value (IN RS)

Reserves

Calculated EPS

10.19

9.21

16.31

13.39

Calculated EPS (Annualised)

40.79

36.86

65.24

53.56

No of Public Share Holdings

112617915

112606287

100683526

100674526

% of Public Share Holdings

27.3

27.29

25.13

PBIDTM% (Excl OI)

22.18

25.69

27.63

23.56

PBIDTM%

30.34

28.08

31.18

27.03

PBDTM%

24.16

21.24

30.95

26.66

PBTM%

16.66

15.29

27.52

22.93

PATM%

13.85

11.79

21.33

18.63

Notes

Risk Disclosures on Derivatives

Quarterly Results

MANKIND PHARMA LTD.